Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Cash Flows From Operating Activities:
Consolidated Net Income	$ 4,848	$ 5,111	$ 4,096
Adjustments to Reconcile Net Income to Net Cash Provided by (Used in) Operating Activities:
Provision for Loan Losses	4,237	1,220	1,200
Depreciation and Amortization	1,181	1,299	1,192
Amortization of Purchase Accounting Valuations	(4,529)	(1,818)	(2,332)
Noncash Compensation (Income) Expense	(59)	456	49
Net Amortization of Securities	1,750	1,929	1,511
(Gain) Loss on Sales of Securities	(31)	(232)	15
Noncash (Income) Loss on Other Equity Securities	(243)	14	(10)
(Gain) Loss on Sale of Premises and Equipment		(24)	157
(Gain) Loss on Sale of Other Real Estate Owned, Net of Writedowns	276	(72)	(58)
Increase in Cash Value of Life Insurance	(633)	(788)	(637)
Provision (Credit) for Deferred Income Taxes	3,126	953	(74)
Changes in Assets and Liabilities:
Increase in Accrued Interest Receivable	(726)	(561)	(314)
(Increase) Decrease in Other Assets	(675)	659	(971)
Increase (Decrease) in Accrued Interest Payable	(30)	354	(76)
Decrease in Other Liabilities	(524)	(350)	(350)
Net Cash Provided by Operating Activities	7,968	8,150	3,398
Cash Flows From Investing Activities:
Purchases of Securities Available for Sale	(8,581)	(45,935)	(58,648)
Proceeds from Maturities / Sales of Securities Available for Sale	7,881	30,589	9,528
Proceeds from Paydowns of Securities Available for Sale	19,625	23,828	19,376
Net Cash Received in Merger			87,377
Purchases of Other Equity Securities	(2,453)	(866)	(3,375)
Redemption of Other Equity Securities	189	82	1,912
Life Insurance Proceeds		560
Net Increase in Loans	(164,419)	(38,326)	(70,443)
Proceeds from Sale of Premises and Equipment		68
Purchases of Premises and Equipment	(505)	(1,390)	(962)
Proceeds from Sales of Other Real Estate	1,084	1,659	2,697
Improvements to Other Real Estate		(102)
Consideration Settlement to Former AGFC Shareholders		(3,448)	(243)
Net Increase in Federal Funds Sold	(6,264)	(60)	(1,339)
Net Cash Used in Investing Activities	(153,443)	(33,341)	(14,120)
Cash Flows From Financing Activities:
Net Increase in Deposits	122,738	28,559	33,775
Net Increase (Decrease) in Securities Sold Under Agreements to Repurchase	(781)	285	(1,841)
Net Advances (Repayments) on Federal Home Loan Bank Borrowings	28,606	(1,349)	(6,511)
Net Increase (Decrease) in Short Term Borrowings		(2,138)	3,000
Net Proceeds (Repayments) from Long Term Borrowings	(300)	3,000
Proceeds from Issuance of Common Stock	62,455
Repurchase of Common Stock	(33)	(863)	(2,805)
Proceeds from Exercise of Stock Warrants		15
Payment of Dividends on Common Stock	(1,792)	(1,056)
Net Cash Provided by Financing Activities	210,893	26,453	25,618
Net Increase in Cash and Cash Equivalents	65,418	1,262	14,896
Cash and Cash Equivalents at Beginning of Period	42,173	40,911	26,015
Cash and Cash Equivalents at End of Period	107,591	42,173	40,911
Supplemental Disclosures for Cash Flow Information:
Interest on Deposits	6,351	4,779	3,813
Interest on Borrowings	908	693	467
Income Tax Payments	1,800	1,016	2,513
Supplemental Schedule for Noncash Investing and Financing Activities:
Change in the Unrealized Gain (Loss) on Securities Available for Sale	1,450	(2,336)	(221)
Change in Deferred Tax Effect on the Unrealized (Gain) Loss on Securities Available for Sale	(493)	795	75
Transfer of Loans to Other Real Estate	566	648	1,033
Transfer of Other Real Estate to Premises and Equipment	$ 175